Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Hogge

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Blood|July 1, 1991
Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layerC J Eaves, J D Cashman, R J Kay, et al.
Bone Marrow Transplantation|January 1, 1991
Human hematopoietic stem cells in long-term culture: quantitation and manipulationM J Barnett, H J Sutherland, A C Eaves, et al.
Blood|August 1, 1994
Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot studyM J Barnett, C J Eaves, G L Phillips, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver StudyM J Barnett, C J Eaves, G L Phillips, et al.
Blood|July 15, 1995
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapyD E Reece, M J Barnett, J D Shepherd, et al.
Leukemia|April 14, 2000
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemiasA E Frankel, J A McCubrey, M S Miller, et al.
Journal of Hematotherapy & Stem Cell Research|July 14, 2000
Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulinK G McCaul, T J Nevill, M J Barnett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Shifting to outpatient management of acute myeloid leukemia: a prospective experienceM L Savoie, T J Nevil, K W Song, et al.
European Journal of Haematology|November 15, 2002
Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22)M D Seftel, H Bruyere, M Copland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2007
Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemiaT Y Halim, K W Song, M J Barnett, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Blood|July 1, 1991
Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layerC J Eaves, J D Cashman, R J Kay, et al.
Bone Marrow Transplantation|January 1, 1991
Human hematopoietic stem cells in long-term culture: quantitation and manipulationM J Barnett, H J Sutherland, A C Eaves, et al.
Blood|August 1, 1994
Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot studyM J Barnett, C J Eaves, G L Phillips, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver StudyM J Barnett, C J Eaves, G L Phillips, et al.
Blood|July 15, 1995
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapyD E Reece, M J Barnett, J D Shepherd, et al.
Leukemia|April 14, 2000
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemiasA E Frankel, J A McCubrey, M S Miller, et al.
Journal of Hematotherapy & Stem Cell Research|July 14, 2000
Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulinK G McCaul, T J Nevill, M J Barnett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Shifting to outpatient management of acute myeloid leukemia: a prospective experienceM L Savoie, T J Nevil, K W Song, et al.
European Journal of Haematology|November 15, 2002
Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22)M D Seftel, H Bruyere, M Copland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2007
Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemiaT Y Halim, K W Song, M J Barnett, et al.
Pageof 9